Yukiko Takamoto-Matsui

Alpha-galactosylceramide-driven immunotherapy for allergy.

Y. Ishii, H. Nishikawa, Annabelle Teng, 2008, Frontiers in bioscience : a journal and virtual library.

Production of Both IL-27 and IFN-γ after the Treatment with a Ligand for Invariant NK T Cells Is Responsible for the Suppression of Th2 Response and Allergic Inflammation in a Mouse Experimental Asthma Model1

Y. Ishii, Z. Ikezawa, Annabelle Teng, 2009, The Journal of Immunology.

Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with alpha-galactosylceramide in vivo.

Y. Ishii, Annabelle Teng, Y. Tamura, 2008, Biochemical and biophysical research communications.

Mouse Experimental Asthma Model aTh 2 Response and Allergic Inflammation in Cells Is Responsible for the Suppression of Treatment with a Ligand for Invariant NK T after the γ Production of Both IL-27 and IFN-Ikezawa and Yasuyuki

Y. Ishii, Z. Ikezawa, Annabelle Teng, 2009 .

Alpha-galactosylceramide-driven immunotherapy for allergy.

Y. Ishii, H. Nishikawa, Annabelle Teng, 2008, Frontiers in bioscience : a journal and virtual library.